BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Gemini Therapeutics

Gemini Therapeutics logo

Founded
2015
Geography
United States of America based
Funding
$44.500 M

Gemini Therapeutics is a precision medicine company focused on genetically-defined dry age-related macular degeneration (AMD) and associated rare genetic diseases.Their therapeutic candidates are matched to molecular abnormalities found in patients with high clinical need and our broad multimodal pipeline includes monoclonal antibodies, recombinant proteins and gene therapies.

Technologies

Gene Therapy Startups  

R&D Platform


Pipelines

No pipelines published yet

Products

 

Services

No services posted yet